載入...

Tetrabenazine in the treatment of Huntington’s disease

Tetrabenazine (TBZ), a catecholamine-depleting agent initially developed for the treatment of schizophrenia, when tested for other indications, has proven to be more useful for the treatment of a variety of hyperkinetic movement disorders. These disorders include neurological diseases characterized...

全面介紹

Na minha lista:
書目詳細資料
主要作者: Paleacu, Diana
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2007
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2656291/
https://ncbi.nlm.nih.gov/pubmed/19381278
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!